Patents by Inventor Stephen J. Fey

Stephen J. Fey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biochemical markers of the human endometrium
    Patent number: 7655471
    Abstract: Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or adenocarcinoma.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: February 2, 2010
    Assignee: Drugmode APS
    Inventors: Inger Byrjalsen, Peter M. Larsen, Stephen J. Fey
  • PROTEINS IN TYPE 2 DIABETES
    Publication number: 20090155814
    Abstract: The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of diabetes related diseases.
    Type: Application
    Filed: November 19, 2008
    Publication date: June 18, 2009
    Applicant: PRIDE PROTEOMICS A/S
    Inventors: Kurt HOJLUND, Stephen J. Fey, Peter Mose Larsen, Henning Beck-Neilsen, Krzysztof Wrzesinski
  • Diabetes-mediating proteins and therapeutic uses thereof
    Patent number: 7531323
    Abstract: Provided are protective and deleterious diabetes-mediating proteins and polynucleotides encoding same, transgenic animals expressing a diabetes-mediating protein, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of altering the expression of a diabetes-mediating protein.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: May 12, 2009
    Inventors: Peter Mose Larsen, Stephen J. Fey, Jorn Nerup, Allan E. Karlsen, Ulla Bjerre Christensen, Flemming Pociot, Henrik U. Andersen
  • Human diabetes-mediating proteins
    Patent number: 7521193
    Abstract: Determining the expression level of certain diabetes-mediating proteins provides an approach both for diagnosing diabetes and for ascertaining a predisposition for developing diabetes.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: April 21, 2009
    Assignee: Pride Proteomics A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Jørn Nerup, Allan E. Karlsen
  • Proteins in type 2 diabetes
    Patent number: 7470542
    Abstract: The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of the diabetes related diseases.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: December 30, 2008
    Assignee: Pride Proteomics A/S
    Inventors: Kurt Højlund, Stephen J. Fey, Peter Mose Larsen, Henning Beck-Nielsen, Krzysztof Wrzesinski
  • METHOD FOR DIAGNOSING DIABETES IN A MAMMAL
    Publication number: 20080145868
    Abstract: Provided are mammalian secreted and non-secreted diabetes mediating proteins, including protective and deleterious diabetes-mediating proteins, as well as polynucleotides encoding same, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of the expression of a diabetes-mediating protein.
    Type: Application
    Filed: October 9, 2007
    Publication date: June 19, 2008
    Applicant: PRIDE PROTEOMICS A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Allan E. Karlsen, Thomas Sparre, Jorn Nerup
  • Method for diagnosing diabetes in a mammal
    Patent number: 7279274
    Abstract: Provided are mammalian secreted and non-secreted diabetes mediating proteins, including protective and deleterious diabetes-mediating proteins, as well as polynucleotides encoding same, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of the expression of a diabetes-mediating protein.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: October 9, 2007
    Assignee: Pride Proteomics A/S
    Inventors: Peter Mose Larsen, Stephen J. Fey, Allan E. Karlsen, Thomas Sparre, Jorn Nerup
  • Diabetes-mediating proteins and therapeutic uses thereof
    Patent number: 7078375
    Abstract: Provided are protective and deleterious diabetes-mediating proteins and polynucleotides encoding same, transgenic animals expressing a diabetes-mediating protein, drug screening methods for identifying a test compound capable of altering the expression of a diabetes-mediating protein, and methods of preventing or ameliorating diabetes by administering a compound capable of altering the expression of a diabetes-mediating protein.
    Type: Grant
    Filed: October 24, 1997
    Date of Patent: July 18, 2006
    Inventors: Peter Mose Larsen, Stephen J. Fey, Jorn Nerup, Allan E. Karlsen, Ulla Bjerre Christensen, Flemming Pociot, Henrik U. Andersen
  • Method and apparatus for analyzing images
    Patent number: 6640000
    Abstract: A method and apparatus for analyzing images is provided that uses a master composite image, generated by averaging selected images, to analyze and interpret an existing or new image. This significantly reduces the amount of time and operator effort required to interpret an image. The invention also provides for comparison between individual images. The present invention can be used for analyzing gel electrophoresis images to identify new proteins, and to compare gel images to identify changes in proteins.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: October 28, 2003
    Inventors: Stephen J. Fey, Peter Mose Larsen
  • Proteome analysis for characterization of up-and down-regulated proteins in biological samples
    Patent number: 6611766
    Abstract: Methods and computer systems are provided for analyzing cell proteomes to characterize proteins that are up- or down-regulated under different conditions, such as under abnormal or compound treated conditions, including drug screening and testing, as well as proteins and encoding or complementary nucleic acids characterized using such methods and computer systems.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: August 26, 2003
    Inventors: Peter Mose Larsen, Stephen J. Fey
  • Biochemical markers of the human endometrium
    Publication number: 20030044795
    Abstract: Assay methods are provided for detection or quantitation of any of several proteins which are specifically produced in the endometrium in association with hyperplasia, adenocarcinoma or the proliferative phase of the endometrium. The relevant proteins have been identified by 2D gel electrophoresis with subsequent sequence identification by mass spectroscopic finger printing of tryptic digests.
    Type: Application
    Filed: August 24, 2001
    Publication date: March 6, 2003
    Inventors: Inger Byrajalsen, Peter M. Larsen, Stephen J. Fey